Discontinued — last reported Q1 '26
Non-US — Sales
Merck & Co. Non-US — Sales decreased by 1.9% to $7.12B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.6%, from $7.01B to $7.12B. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests successful international market penetration or favorable global demand, while a decrease may indicate competitive pressure, regulatory hurdles, or adverse currency impacts in foreign regions.
Detailed definition
This metric represents the total revenue generated by the company from operations and product sales outside of its home...
Peer comparison
Most multinational pharmaceutical companies report international revenue as a key segment, often comparing it against domestic sales to evaluate geographic diversification.
mrk_segment_non_us_salesHistorical Data
| Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.02B | $8.25B | $8.30B | $8.24B | $7.92B | $7.44B | $7.01B | $6.97B | $7.26B | $7.26B | $7.12B |
| QoQ Change | — | +2.9% | +0.6% | -0.7% | -3.8% | -6.1% | -5.8% | -0.5% | +4.2% | -0.0% | -1.9% |
| YoY Change | — | — | — | +2.7% | -3.9% | — | -15.5% | -15.4% | -8.3% | -2.4% | +1.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s non-us — sales?
- Merck & Co. (MRK) reported non-us — sales of $7.12B in Q1 2026.
- How has Merck & Co.'s non-us — sales changed year-over-year?
- Merck & Co.'s non-us — sales increased by 1.6% year-over-year, from $7.01B to $7.12B.
- What does non-us — sales mean?
- The total revenue earned by the company from sales in all countries outside of its home market.